Airway Fusobacterium is Associated with Poor Response to Immunotherapy in Lung Cancer

PURPOSE: There is a major limitation in the immunotherapy for solid cancer is that it only benefited a minority of cancer patients. This study aims to investigate whether the differential composition of the lung microbiome could affect the sustained clinical responses in lung cancers treated with im...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Shujuan, Cheng, Zaixing, Yin, Zhongyuan, Xu, Juanjuan, Wu, Feng, Jin, Yang, Yang, Guanghai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896836/
https://www.ncbi.nlm.nih.gov/pubmed/35250279
http://dx.doi.org/10.2147/OTT.S348382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896836/
https://www.ncbi.nlm.nih.gov/pubmed/35250279
http://dx.doi.org/10.2147/OTT.S348382

Ejemplares similares